🚀 YZi Labs Appoints Jane He as General Partner to Lead Biotech Investments
#YZiLabs #JaneHe #GeneralPartner #BiotechInvestments #AI #Web3 #CancerTherapies #GeneEditing #MetabolicTreatments #AIDriven #Medtech #DisruptiveOpportunities #NextGenerationHealthcare #ScientificInnovation
YZi Labs has announced the appointment of Jane He as General Partner, where she will spearhead biotech investments while also contributing to the firm’s AI and Web3 strategy.Key Highlights:Jane He brings a wealth of experience in biotech and medtech, focusing on cancer therapies, gene editing, metabolic treatments, and AI-driven biotech solutions.Her background includes an investment leadership role as COO at a Hong Kong-based hedge fund, where she specialized in growth-stage investments in biotech and other innovation-driven sectors.A Stanford GSB graduate, Jane has a proven track record of identifying disruptive opportunities at the intersection of biotech, AI, and next-generation healthcare technologies.YZi Labs aims to expand its biotech portfolio, emphasizing AI-driven medical advancements and transformative scientific innovation.#YZiLabs #JaneHe #GeneralPartner #BiotechInvestments #AI #Web3 #CancerTherapies #GeneEditing #MetabolicTreatments #AIDriven #Medtech #DisruptiveOpportunities #NextGenerationHealthcare #ScientificInnovation